Stockreport

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, Nov. 03, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development compan [Read more]